Pradžia › Smegenų navikai › Virginia
Smegenų navikai klinikiniai tyrimai Virginia
15 tyrimai dėl Smegenų navikai ieško dalyvių vietose Virginia.
Miestai Virginia
Oficialus tyrimo tekstas (anglų kalba)
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Inova Schar Cancer Institute, Fairfax
- VCU Massey Comprehensive Cancer Center, Richmond
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07326566C-SMART vs BE Well for Patients With Brain Tumors
- Virginia Commonwealth University, Richmond
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07224503Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- NEXT Virginia, Fairfax
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-16 · NCT05786924A Phase 1/1b Study of IAM1363 in HER2 Cancers
- NEXT Oncology - Virginia Cancer Specialists, Fairfax
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-09 · NCT06253871FearLess in NeuroOncology
- Virginia Commonwealth University, Richmond
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-09 · NCT06989086Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- Virginia Cancer Institute, Norfolk
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-09 · NCT05386108A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
- Inova Center for Personalized Health, Fairfax
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-08 · NCT07428616A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases
- Next Oncology -Virginia, Fairfax
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-17 · NCT06136884Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
- INOVA Health, Fairfax
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-07-22 · NCT04427384Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- University of Virginia Comprehensive Cancer Center, Charlottesville
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Moterims · Atnaujinta 2026-07-21 · NCT04348747Pain Control and Quality of Recovery After Intravenous Methadone Versus Intravenous Remifentanil in Craniotomy Surgery
- University of Virginia, Charlottesville
Renkami dalyviaiAnkstyvoji 1 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-05-04 · NCT06810336Sonodynamic Therapy in Patients With Recurrent GBM
- University of Virginia, Charlottesville
Renkami dalyviai1 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-04-28 · NCT06039709Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- NEXT Virginia, Fairfax
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-13 · NCT06810544S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- Augusta Health Center for Cancer and Blood Disorders, Fishersville
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-10-08 · NCT03418961A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.
- NEXT Virginia, Fairfax
Renkami dalyviai1/2 fazė
Amžius nuo 18 iki 89 · Visoms lytims · Atnaujinta 2025-08-19 · NCT06907043Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.